Edwards Lifesciences Corp.
Company Snapshot
Company Overview
Edwards Lifesciences offers medical devices for critical care, vascular, and structural heart disease, and technologies to treat advanced CVD and other critical illnesses.
The company categorizes its products and technologies into four main areas: Transcatheter Aortic Replacement; Transcatheter Mitral and Tricuspid Therapies; Surgical Structural Heart; and Critical Care. The company operates in four reporting segments: the U.S., Europe, Japan and the Rest of the World. As of Dec. 31, 2021, the company had 15,700 employees worldwide.
The company manufactures heart valve systems for surgical and transcatheter therapies for heart valve replacement and repair. The company also offers transcatheter heart valves, including transcatheter aortic heart valves and their delivery for the nonsurgical replacement of heart valves, surgical heart valve therapy products and repair products, and minimally invasive monitoring systems, pressure-monitoring products, hemofiltration products and vascular stents.
Financial Highlights (FY 2023)
This information is available for BCC Research members only.
Edwards Lifesciences Corp. In Reports
Edwards Lifesciences Corp. In News
Applications/End User Industries
- Anesthesia
- Heart Valves
- Valve Replacement
- Tricuspid Therapies
- Symptomatic Aortic Stenosis
- Heart Surgical Therapies
- Heart Valve Repair
- Heart Valve Replacement
- Tricuspid Valve Replacement
- Transcatheter Treatment
- Surgical Therapy
- Hemodynamic Monitoring System
- Arterial Pressure Monitoring Products
- Tricuspid Therapy
